CMHC Faculty Members

Faculty of Tarsus Medical Group are leaders in healthcare

Sergio Fazio


Biography: Sergio Fazio



  • The William and Sonja Connor
  • Chair of Preventive Cardiology
  • Professor of Medicine and Physiology & Pharmacology
  • Director, Center for Preventive Cardiology
  • Knight Cardiovascular Institute
  • Oregon Health and Science University
  • Portland, OR


A graduate of the medical school of the University of Rome, Italy, Dr. Fazio continued at the same institution with a fellowship in Metabolic Diseases. In 1985, he undertook a Ph.D. program in Experimental Medicine at the University of Siena, Italy, and completed it at the University of California, San Francisco (UCSF). In 1988 Dr. Fazio joined the Gladstone Institute of Cardiovascular Disease, UCSF, as a postdoctoral scientist first, and then as a staff scientist (Instructor in Medicine, UCSF).

In 1993 Dr. Fazio joined the faculty of the School of Medicine at Vanderbilt University as an Assistant Professor in the Division of Endocrinology and Diabetes. There, he co-founded the Vanderbilt Lipid Clinic and became Director of the Vanderbilt Lipid Laboratory. He was promoted to the rank of Associate Professor in July 1998. In November of 1999 Dr. Fazio joined the Division of Cardiovascular Medicine to become the co-Director of the Atherosclerosis Research Unit. He was promoted to Professor in November 2002. In 2011 he was appointed the Cornelius Vanderbilt Chair of Cardiovascular Medicine and Chief of the section of Cardiovascular Disease Prevention. Since July 2014 he holds the William and Sonja Connor chair of Preventive Cardiology at the KCVI of OHSU.

His clinical interest is the management of dyslipidemia patients. He participates in clinical trials to study the effectiveness and efficacy of lipid-lowering drugs, and to identify mutations causing altered lipid levels in humans. Dr. Fazio’s NIH-supported research portfolio focuses on the pathogenesis of genetic dyslipidemias, the early cellular events in atherogenesis, and gene therapy approaches to atherosclerosis. He has been an Established Investigator of the American Heart Association and has received over 15 major NIH grants in the course of his career. He has published over 220 papers, including original articles, reviews, editorials, and book chapters. He has been a charter member of the Study Section Atherosclerosis and Inflammation in Cardiovascular Disease of the NIH-NHLBI from 2006 to 2010. He is member of the American Society for Clinical Investigation and of the Association of American Physicians. He is on the editorial board of Arteriosclerosis, Thrombosis and Vascular Biology, Journal of Lipid Research,and Circulation Research, and is an associate editor for the Journal of Clinical Lipidology. He currently holds the office of Secretary at the American Board of Clinical Lipidology.

Subscribe to "The Monthly Beat" Newsletter

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.

A division of Tarsus Medical owned by Tarsus Group

Cardiometabolic Health Congress
1801 N Military Trail, Ste 200
Boca Raton, FL, 33431

Copyright © 2021, Cardiometabolic Health Congress. All Rights Reserved.


Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.